Genomics into health

As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare

We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.

Report Control of patient information in the COVID-19 era

The control of patient information (COPI) notices have had significant positive impacts on COVID-19 - related research, but the success of future reforms to the use of CPI relies on building trustworthiness.

Policy briefing CAR-T cell therapies

CAR-T cell therapies are a form of cellular immunotherapy that use genetically modified T cells, a type of white blood cell.

Blog Genome UK: new four nations commitments to priority actions

18 March 2022

New commitments for UK-wide implementation of genomics have been announced that aim to accelerate research and drive healthcare innovation.

Blog Using genomics to improve drug prescribing

4 April 2022

A recent joint report has outlined guidance, barriers and opportunities around the use of pharmacogenomics.

Report Our healthy future

What do we want our healthy future to look like, and how can we ensure science helps our path towards that future?

Briefing Antisense oligonucleotide therapies

3 September 2021

Policy briefing on ASOs and their RNA molecule targeting

Explainer Pharmacogenomics

16 August 2021

What is pharmacogenomics?

Explainer Nutritional genomics

29 July 2021

Nutrients in our diet affect how our bodies function and our overall health.

Explainer Microbiome analysis and manipulation

27 July 2021

A short overview of the potential healthcare uses of understanding the microbiome

Explainer What is stem cell therapy?

8 July 2021

A short overview of stem cell therapy

Blog Expanding the public and patient role in medical regulation

6 July 2021

A recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).

Blog Putting Genome UK into practice

18 May 2021